Open access · OA
via OpenAlex
Molecular and cellular drivers of inflammaging: Uncovering the diverse mechanisms and interventions of inflammaging
Joris Van de Walle, Thibaut Delvaux, Arnaud Vandenberghe
Clinical and translational reports · 2025 · ▲ 5 citations
Epigenetic alterations
Dysbiosis
Mitochondrial dysfunction
Cellular senescence
Altered intercellular communication
Chronic inflammation
Disabled macroautophagy
Caloric restriction
Senolytics
Exercise
Partial reprogramming (OSK)
Microbiome / FMT
Human
Review
Abstract
Aging is accompanied by a persistent state of low-grade inflammation, widely referred to as “inflammaging(definition)”. Unlike acute inflammation, which is transient and protective, inflammaging represents a chronic, sterile, systemic process that accelerates tissue dysfunction and predisposes individuals to age-related diseases. Its origins are multifactorial, involving cellular senescence(definition), impaired autophagy(definition), mitochondrial dysfunction(definition), dysregulated innate immune signaling, epigenetic alterations, and shifts in gut microbiota composition. These mechanisms converge to form a self-perpetuating cycle of inflammatory activation that compromises tissue homeostasis. The clinical consequences of inflammaging extend across diverse organ systems. It contributes to neurodegeneration through sustained neuroinflammation, promotes cardiovascular pathology by driving endothelial dysfunction and atherosclerosis, and accelerates pulmonary and musculoskeletal decline. Such broad involvement underscores its role as a unifying mechanism linking aging to chronic disease onset and progression. Therapeutic strategies have begun to target inflammaging directly. Senolytics(definition) eliminate senescent cells, while senomorphics suppress the senescence-associated secretory phenotype (SASP). Modulation of gut microbiota through dietary interventions, probiotics, or fecal microbiota transplantation restores microbial balance and reduces systemic inflammation. Lifestyle modifications, including caloric restriction(definition), exercise, and improved sleep quality, further mitigate inflammatory burden and enhance resilience. This review synthesizes the current research progress on the molecular and cellular drivers of inflammaging and highlights emerging therapeutic approaches to alleviate chronic inflammation and extend healthy lifespan. It aims to provide a comprehensive framework for understanding inflammaging and deepen our understanding of inflammatory mechanisms, which will facilitate early detection, personalized treatment, and efficacy monitoring.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.58832/ctr.2025.10.9.2
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
Walle, J.V.D., Delvaux, T., & Vandenberghe, A. (2025). Molecular and cellular drivers of inflammaging: Uncovering the diverse mechanisms and interventions of inflammaging. <em>Clinical and translational reports</em>. https://doi.org/10.58832/ctr.2025.10.9.2
Vancouver
Walle JVD, Delvaux T, Vandenberghe A. Molecular and cellular drivers of inflammaging: Uncovering the diverse mechanisms and interventions of inflammaging. Clinical and translational reports. 2025. doi:10.58832/ctr.2025.10.9.2.
BibTeX
@article{joris2025Molecu,
title = {Molecular and cellular drivers of inflammaging: Uncovering the diverse mechanisms and interventions of inflammaging},
author = {Joris Van de Walle and Thibaut Delvaux and Arnaud Vandenberghe},
journal = {Clinical and translational reports},
year = {2025},
doi = {10.58832/ctr.2025.10.9.2},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2025
Open access · CC-BY
From Senescent Cells to Systemic Inflammation: The Role of Inflammaging in Age-Related Diseases and Kidney Dysfunction
Cells 2025
Open access · OA
From Senescent Cells to Systemic Inflammation: The Role of Inflammaging in Age-Related Diseases and Kidney Dysfunction.
Immunological investigations 2026
Citation only
Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies.
Immunological Investigations 2026
Citation only
Pharmacological Modulation of Immunosenescence and Inflammaging: Senolytics, Senomorphics, and Emerging Therapies
Immunity & Ageing 2026
Open access · CC-BY
Inflammaging and the role of micronutrients as immunomodulators: a pathway to healthy aging
Immunity & ageing : I & A 2026
Open access · OA